Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 13 Dec 2023 for Acelrx Pharmaceuticals INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Richard Afable: trading record in brief
This profile gathers the share dealings of Richard Afable in Talphera, Inc., where the filings describe the role as board member. In total, 3 filings cover trades dated from 17 June 2021 to 10 October 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 13 December 2023 came the latest disclosure, a share grant in Talphera, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard Afable
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
581 shares0Common StockSEC:0001209191-23-058487:0
15,500 shares0Common StockSEC:0001209191-22-042309:0
10,000 shares0Common StockSEC:0001209191-21-041571:0
3 of 3 declarations
